Originally published In Press as doi:10.1074/jbc.M414407200 on March 28, 2005
J. Biol. Chem., Vol. 280, Issue 23, 22454-22461, June 10, 2005
Characterization of Heparin Affin Regulatory Peptide Signaling in Human Endothelial Cells*
Apostolos Polykratis
¶,
Panagiotis Katsoris
,
José Courty||, and
Evangelia Papadimitriou
**
From the
Laboratory of Molecular Pharmacology, Department of Pharmacy, and the
Division of Genetics, Cell and Developmental Biology, Department of Biology, University of Patras, 26504 Patras, Greece, and the ||Laboratoire de la Recherche sur la Croissance Cellulaire, la Reparation et la Regeneration Tissulaires, CNRS UMR 7149, Université Paris Val de Marne, Avenue du Général de Gaulle, 94010 Créteil, France
Heparin affin regulatory peptide (HARP) is an 18-kDa secreted growth factor that has a high affinity for heparin and a potent role on tumor growth and angiogenesis. We have previously reported that HARP is mitogenic for different types of endothelial cells and also affects cell migration and differentiation (12). In this study we examined the signaling pathways involved in the migration and tube formation on matrigel of human umbilical vein endothelial cells (HUVEC) induced by HARP. We report for the first time that receptor-type protein-tyrosine phosphatase
/
(RPTP
/
), which is a receptor for HARP in neuronal cell types, is also expressed in HUVEC. We also document that HARP signaling through RPTP
/
leads to activation of Src kinase, focal adhesion kinase, phosphatidylinositol 3-kinase, and Erk1/2. Sodium orthovanadate, chondroitin sulfate-C, PP1, wortmannin, LY294002, and U0126 inhibit HARP-mediated signaling and HUVEC migration and tube formation. In addition, RPTP
/
suppression using small interfering RNA technology interrupts intracellular signals and HUVEC migration and tube formation induced by HARP. These results establish the role of RPTP
/
as a receptor of HARP in HUVEC and elucidate the HARP signaling pathway in endothelial cells.
Received for publication, December 22, 2004
, and in revised form, March 24, 2005.
* This work was supported by grants from the Research Committee of the University of Patras (Karatheodoris) and Empeirikio Foundation, Greece. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ A recipient of a fellowship from the State Scholarships Foundation.
** To whom correspondence should be addressed. Tel.: 30-2610-969336; Fax: 30-2610-997665; E-mail: epapad{at}upatras.gr.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. Fukazawa, S. Yokoyama, M. Eiraku, M. Kengaku, and N. Maeda
Receptor Type Protein Tyrosine Phosphatase {zeta}-Pleiotrophin Signaling Controls Endocytic Trafficking of DNER That Regulates Neuritogenesis
Mol. Cell. Biol.,
July 15, 2008;
28(14):
4494 - 4506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-J. Pyun, S. Choi, Y. Lee, T.-W. Kim, J.-K. Min, Y. Kim, B.-D. Kim, J.-H. Kim, T.-Y. Kim, Y.-M. Kim, et al.
Capsiate, a Nonpungent Capsaicin-Like Compound, Inhibits Angiogenesis and Vascular Permeability via a Direct Inhibition of Src Kinase Activity
Cancer Res.,
January 1, 2008;
68(1):
227 - 235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. U. Magnusson, A. Dimberg, S. Mellberg, A. Lukinius, and L. Claesson-Welsh
FGFR-1 regulates angiogenesis through cytokines interleukin-4 and pleiotrophin
Blood,
December 15, 2007;
110(13):
4214 - 4222.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Muramatsu, P. Zou, N. Kurosawa, K. Ichihara-Tanaka, K. Maruyama, K. Inoh, T. Sakai, L. Chen, M. Sato, and T. Muramatsu
Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors
Genes Cells,
December 1, 2006;
11(12):
1405 - 1417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hatziapostolou, C. Polytarchou, P. Katsoris, J. Courty, and E. Papadimitriou
Heparin Affin Regulatory Peptide/Pleiotrophin Mediates Fibroblast Growth Factor 2 Stimulatory Effects on Human Prostate Cancer Cells
J. Biol. Chem.,
October 27, 2006;
281(43):
32217 - 32226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Milan, C. Charalambous, R. Elhag, T. C. Chen, W. Li, S. Guan, F. M. Hofman, and R. Zidovetzki
Multiple signaling pathways are involved in endothelin-1-induced brain endothelial cell migration
Am J Physiol Cell Physiol,
July 1, 2006;
291(1):
C155 - C164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Maeda, N. Fukazawa, and T. Hata
The Binding of Chondroitin Sulfate to Pleiotrophin/Heparin-binding Growth-associated Molecule Is Regulated by Chain Length and Oversulfated Structures
J. Biol. Chem.,
February 24, 2006;
281(8):
4894 - 4902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Polytarchou, M. Hatziapostolou, and E. Papadimitriou
Hydrogen Peroxide Stimulates Proliferation and Migration of Human Prostate Cancer Cells through Activation of Activator Protein-1 and Up-regulation of the Heparin Affin Regulatory Peptide Gene
J. Biol. Chem.,
December 9, 2005;
280(49):
40428 - 40435.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.